椎动脉近端支架植入术后支架内再狭窄危险因素分析

doi:10.3969/j.issn.1672-6731.2020.06.010

中国现代神经疾病杂志 ›› 2020, Vol. 20 ›› Issue (6): 528-533. doi: 10.3969/j.issn.1672-6731.2020.06.010

2 椎动脉近端支架植入术后支架内再狭窄危险因素分析

陆军, 吴卓毅, 王俊杰, 祁鹏, 王大明

100730 北京医院神经外科国家老年医学中心

收稿日期:2020-06-17 出版日期:2020-06-25 发布日期:2020-06-24
通讯作者: 王大明,Email:daming2000@263.net
基金资助:
中国医学科学院中央级公益性科研院所基本科研业务费专项基金资助项目（项目编号：2019TX320002）

Analysis of risk factors for in-stent restenosis after proximal vertebral artery stent implantation

LU Jun, WU Zhuo-yi, WANG Jun-jie, QI Peng, WANG Da-ming

Department of Neurosurgery, Beijing Hospital;National Center of Gerontology, Beijing 100730, China

Received:2020-06-17 Online:2020-06-25 Published:2020-06-24
Supported by:
This study was supported by Non - Profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No. 2019TX320002).

摘要/Abstract

摘要：

目的探讨椎动脉近端支架植入术后支架内再狭窄的危险因素。方法以2007年1月至2017年6月行椎动脉近端支架植入术且术后经CTA或DSA随访的155例椎动脉近端狭窄致后循环缺血患者为观察对象，通过DSA观察椎动脉近端支架植入侧别、支架直径和长度、支架类型（裸金属支架或药物洗脱支架）、椎动脉近端狭窄改善情况，单因素和多因素前进法Logistic回归分析探讨术后支架内再狭窄相关危险因素。结果 155例患者共植入178枚球囊扩张式支架，支架内再狭窄率为30.90%（55/178）。Logistic回归分析显示，合并基底动脉狭窄（OR=4.468，95% CI：1.685~11.849；P=0.003）和支架直径2.5~3.5 mm（OR=5.126，95% CI：1.748~15.033；P=0.003）是椎动脉近端支架植入术后支架内再狭窄的危险因素。结论合并基底动脉狭窄和植入支架直径偏小是椎动脉近端支架植入术后支架内再狭窄的危险因素。

关键词: 椎底动脉供血不足, 血管成形术, 支架, 危险因素, Logistic模型

Abstract:

Objective To investigate risk factors for in-stent restenosis after proximal vertebral artery (VA) stenting. Methods One hundred and fifty-five patients underwent balloon-expandable stent assisted-angioplasty for symptomatic proximal VA stenosis from Januray 2007 to June 2017, and CTA or DSA were examined. The risk factors for in-sent restenosis after proximal VA stenting were investigated via univariate and multivariate forward Logistic regression analysis. Results One hundred and fifty-five patients were treated with 178 balloon-expandable stents. The in-sent restenosis rate was 30.90% (55/178). Univariate and multivariate forward Logistic regression analysis found that coexist of basilar artery stenosis (OR=4.468, 95% CI:1.685-11.849; P=0.003) and stent diameter 2.5-3.5 mm (OR=5.126, 95% CI:1.748-15.033; P=0.003) were risk factors for in-sent restenosis. Conclusions Coexist of basilar artery stenosis and smaller stent diameter were risk factors for in-stent restenosis after proximal VA stentintg.

Key words: Vertebrobasilar insufficiency, Angioplasty, Stents, Risk factors, Logistic models

陆军, 吴卓毅, 王俊杰, 祁鹏, 王大明. 椎动脉近端支架植入术后支架内再狭窄危险因素分析[J]. 中国现代神经疾病杂志, 2020, 20(6): 528-533.

LU Jun, WU Zhuo-yi, WANG Jun-jie, QI Peng, WANG Da-ming. Analysis of risk factors for in-stent restenosis after proximal vertebral artery stent implantation[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2020, 20(6): 528-533.

https://journal11.magtechjournal.com/cjcnn/CN/Y2020/V20/I6/528

参考文献

[1] Antoniou GA, Murray D, Georgiadis GS, Antoniou SA, Schiro A, Serracino-Inglott F, Smyth JV. Percutaneous transluminal angioplasty and stenting in patients with proximal vertebral artery stenosis[J]. J Vasc Surg, 2012, 55:1167-1177.
[2] Taylor RA, Siddiq F, Suri MF, Martin CO, Hayakawa M, Chaloupka JC. Risk factors for in-stent restenosis after vertebral ostium stenting[J]. J Endovasc Ther, 2008, 15:203-212.
[3] Zhou Z, Yin Q, Xu G, Yue X, Zhang R, Zhu W, Fan X, Ma M, Liu X. Influence of vessel size and tortuosity on in-stent restenosis after stent implantation in the vertebral artery ostium[J]. Cardiovasc Intervent Radiol, 2011, 34:481-487.
[4] North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis[J]. N Engl J Med, 1991, 325:445-453.
[5] Metz H, Murray-Leslie RM, Bannister RG, Bull JW, Marshall J. Kinking of the internal carotid artery[J]. Lancet, 1961, 1:424-426.
[6] Lee YJ, Lim YS, Lim HW, Yu IK, Kim YJ, Yoo WJ. Evaluation of in-stent restenosis after stent implantation in the vertebral artery ostium by multislice computed tomography angiography:factors affecting accurate diagnosis[J]. Clin Neuroradiol, 2015, 25:379-386.
[7] Hatano T, Tsukahara T, Miyakoshi A, Arai D, Yamaguchi S, Murakami M. Stent placement for atherosclerotic stenosis of the vertebral artery ostium:angiographic and clinical outcomes in 117 consecutive patients[J]. Neurosurgery, 2011, 68:108-116.
[8] Lin YH, Juang JM, Jeng JS, Yip PK, Kao HL. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents:clinical results and restenosis analysis[J]. J Endovasc Ther, 2004, 11:719-726.
[9] Süselbeck T, Latsch A, Siri H, Gonska B, Poerner T, Pfleger S, Schumacher B, Borggrefe M, Haase KK. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus[J]. Am J Cardiol, 2001, 88:243-247.
[10] Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ. Primary renal artery stenting:characteristics and outcomes after 363 procedures[J]. Am Heart J, 2001, 142:314-323.
[11] Lazzaro MA, Badruddin A, Abraham MG, Edgell RC, Zaidat OO. Proposed angiographic criteria for measurement of vertebral artery origin stenosis:the vertebral origin treatment with endovascular therapy (VOTE) method[J]. J Stroke Cerebrovasc Dis, 2012, 21:712-716.
[12] Dishmon DA, Elhaddi A, Packard K, Gupta V, Fischell TA. High incidence of inaccurate stent placement in the treatment of coronary aorto-ostial disease[J]. J Invasive Cardiol, 2011, 23:322-326.
[13] Dietz U, Holz N, Dauer C, Lambertz H. Shortening the stent length reduces restenosis with bare metal stents:matched pair comparison of short stenting and conventional stenting[J]. Heart, 2006, 92:80-84.
[14] Zhao HP, Li SM. Risk factors of in-stent restenosis of vertebral artery origin[J]. Zhonghua Fang She Xue Za Zhi, 2013, 47:73-76.[赵慧玭, 李慎茂. 椎动脉起始部支架置入术后再狭窄的发生情况及影响因素[J]. 中华放射学杂志, 2013, 47:73-76.]
[15] Al-Lamee R, Ielasi A, Latib A, Godino C, Mussardo M, Arioli F, Figin F, Piraino D, Carlino M, Montorfano M, Chieffo A, Colombo A. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions[J]. Am J Cardiol, 2011, 108:1055-1060.
[16] Stayman AN, Nogueira RG, Gupta R. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis[J]. Stroke, 2011, 42:2212-2216.
[17] Lin YH, Hung CS, Tseng WY, Lee RW, Wang YC, Lin MS, Yeh MH, Chao CL, Ho YL, Jeng JS, Yip PK, Kao HL; National Taiwan University Carotid Artery and Vertebral Artery Stenosis (NTU CAVAS) Study Group. Safety and feasibility of drug-eluting stent implantation at vertebral artery origin:the first case series in Asians[J]. J Formos Med Assoc, 2008, 107:253-258.
[18] Park MS, Fiorella D, Stiefel MF, Dashti SR, Gonzalez LF, McDougall CG, Albuquerque FC. Vertebral artery origin stents revisited:improved results with paclitaxel-eluting stents[J]. Neurosurgery, 2010, 67:41-48.
[19] Ogilvy CS, Yang X, Natarajan SK, Hauck EF, Sun L, Lewis-Mason L, Hopkins LN, Siddiqui AH, Levy EI. Restenosis rates following vertebral artery origin stenting:does stent type make a difference[J]? J Invasive Cardiol, 2010, 22:119-124.
[20] Raghuram K, Seynnaeve C, Rai AT. Endovascular treatment of extracranial atherosclerotic disease involving the vertebral artery origins:a comparison of drug-eluting and bare-metal stents[J]. J Neurointerv Surg, 2012, 4:206-210.
[21] Ortega-Gutierrez S, Lopez GV, Edgell RC, Mendez AA, Dandapat S, Roa JA, Zevallos CB, Holcombe AL, Hasan D, Derdeyn CP, Rossen J, Samaniego EA. Second generation drug-eluting stents for endovascular treatment of ostial vertebral artery atenosis:a single center experience[J]. Front Neurol, 2019, 16:746.
[22] Lee YJ, Lim YS, Lim HW, Yoo WJ, Choi BG, Kim BS. Diagnostic accuracy of 64-slice multidetector CT angiography for detection of in-stent restenosis of vertebral artery ostium stents:comparison with conventional angiography[J]. Acta Radiol, 2014, 55:1000-1007.

选择文件类型/文献管理软件名称

选择包含的内容

2 椎动脉近端支架植入术后支架内再狭窄危险因素分析

Analysis of risk factors for in-stent restenosis after proximal vertebral artery stent implantation

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	倪洋, 张昉, 张勇, 林劲芝. 基于影像组学的神经血管压迫与原发性三叉神经痛关系探讨[J]. 中国现代神经疾病杂志, 2024, 24(8): 668-673.
[2]	梅月昕, 陈歆然, 陈红兵. 急性直窦血栓形成血管内治疗一例[J]. 中国现代神经疾病杂志, 2024, 24(8): 684-688.
[3]	谭波, 张钺, 杨佳强, 刘永东, 焦阳, 王贝. 创伤性脑疝患者去骨瓣减压术后脑积水危险因素分析以及贝叶斯网络模型构建[J]. 中国现代神经疾病杂志, 2024, 24(6): 442-449.
[4]	赵浩, 曲鑫, 王宁, 尚峰, 徐跃峤, 齐猛. 脑积水腰大池-腹腔分流术预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(6): 450-454.
[5]	米晓璐, 齐洪娜, 王维展, 孙少杰, 武艳品. 脂蛋白相关磷脂酶A2联合系统性炎症反应指数对急性一氧化碳中毒迟发性脑病的预测价值[J]. 中国现代神经疾病杂志, 2024, 24(6): 483-490.
[6]	叶睿曦, 蔡林君, 孔雪莹, 李劲梅, 周东, 洪桢. 抗N-甲基-D-天冬氨酸受体脑炎急性期严重程度及短期预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(5): 331-339.
[7]	史美燕, 张贤军, 王宪伟, 张勇, 王乃东. 经桡动脉入路颅内动脉狭窄支架成形术四例[J]. 中国现代神经疾病杂志, 2024, 24(5): 382-390.
[8]	徐坤榕, 王晓娟, 张弥兰, 薛红飞, 徐佳佳, 李玮. 单纯疱疹病毒1型脑炎临床特点及预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(4): 224-229.
[9]	熊冰婕, 曹飘, 张骏, 张海清. 隐球菌性脑膜炎预后不良危险因素分析及列线图预测模型构建[J]. 中国现代神经疾病杂志, 2024, 24(4): 230-237.
[10]	王建宇, 白云鹏. 主动脉夹层围手术期神经系统并发症的危险因素与治疗策略[J]. 中国现代神经疾病杂志, 2024, 24(2): 97-101.
[11]	王培健, 魏铭. 心脑血管疾病的预防与管理策略[J]. 中国现代神经疾病杂志, 2024, 24(2): 106-112.
[12]	贺中正, 李瑞乾, 刘志勇, 龙乾发, 岳树源, 杨彦平. 海拔4000米以上高原地区脑卒中临床特征：附103例分析[J]. 中国现代神经疾病杂志, 2023, 23(9): 859-863.
[13]	王亚伟, 田锋. 不同性别动脉粥样硬化差异性研究进展[J]. 中国现代神经疾病杂志, 2023, 23(9): 864-871.
[14]	冯珊珊. 基于危险因素的库欣病患者视力视野客观检查卫生经济学分析[J]. 中国现代神经疾病杂志, 2023, 23(7): 613-620.
[15]	邹婷婷, 马莉, 潘文静, 李长秀, 胡乃霞, 王擂. 重型颅脑创伤并发颅内感染危险因素分析及列线图预测模型构建[J]. 中国现代神经疾病杂志, 2023, 23(6): 496-502.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 椎动脉近端支架植入术后支架内再狭窄危险因素分析

Analysis of risk factors for in-stent restenosis after proximal vertebral artery stent implantation

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价